TrialSignal
Clinical trial intelligence report
Biofilm-induced Antimicrobial Resistance RIsk ERadication in Critical Care Central Venous Catheters
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT07546994-Jul 28, 2026
NCT ID
NCT07546994
Status
NOT_YET_RECRUITING
Phase
registry-stage
Sponsor
Centre Hospitalier Universitaire de Nīmes
Executive brief
Investment-Ready Snapshot
Biofilm-induced Antimicrobial Resistance RIsk ERadication in Critical Care Central Venous Catheters is a registry-stage clinical asset sponsored by Centre Hospitalier Universitaire de Nīmes in Catheter-Related Infections, Biofilms, Infection Prevention. SEO and diligence focus: Microbial analysis of catheter biofilm, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT07546994
Indication
Catheter-Related Infections
Modality
protein therapy
Target
Microbial analysis of catheter biofilm
Intervention
Microbial analysis of catheter biofilm
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.